Immuno-Oncology | Specialty

Maintenance/Consolidation Therapy in NSCLC

January 30th 2018

Chemoradiotherapy in Unresectable Locally Advanced NSCLC

January 30th 2018

Radiation Therapy in Stage 3 NSCLC

January 30th 2018

Locally Advanced NSCLC: Operable Setting

January 30th 2018

Multimodality Approaches to Locally Advanced NSCLC

January 30th 2018

Treatment of Locally Advanced NSCLC

January 30th 2018

Treatment of Early-Stage NSCLC

January 30th 2018

New Criteria Needed to Evaluate Immunotherapy Responses

January 28th 2018

Most patients who appear to progress after they begin receiving anticancer immunotherapy will never exhibit a response to therapy.

Advances and Research Needs in Lymphoma

January 26th 2018

Investigating CAR T-Cell Therapy in Lymphoma

January 26th 2018

Approval of Acalabrutinib in Mantle Cell Lymphoma

January 26th 2018

Duration of Rituximab Maintenance in FL

January 26th 2018

Long-Term Data With Copanlisib in Follicular Lymphoma

January 26th 2018

Follicular Lymphoma: Obinutuzumab and Chemotherapy

January 26th 2018

MAVORIC Trial in Cutaneous T-Cell Lymphoma

January 26th 2018

Primary Cutaneous T-cell Lymphoma: ALCANZA Trial

January 26th 2018

Role of Novel Therapies in Hodgkin Lymphoma

January 26th 2018

Novel Combinations in Relapsed Hodgkin Lymphoma

January 26th 2018

Hodgkin Lymphoma: Addressing the Elderly Population

January 26th 2018

Hodgkin Lymphoma: Important Findings from CheckMate 205

January 26th 2018